Mohammad Alomari, MD (@alomari_md) 's Twitter Profile
Mohammad Alomari, MD

@alomari_md

🇯🇴IBD Provider @UAMS_GIHep Advanced IBD Fellow @ClevelandClinic Alum GI Fellow/Chief @CleveClinicFL IM Chief @ETSU IM Resident/Chief @ Fairview hospital

ID: 1429803436531453956

linkhttps://scholar.google.com/citations?user=ARJUq_gAAAAJ&hl=en calendar_today23-08-2021 13:51:27

131 Tweet

343 Followers

401 Following

UAMS Division of Gastroenterology & Hepatology (@uams_gihep) 's Twitter Profile Photo

UAMS enthusiastically welcomes Dr. Mohammad Alomari, Director of the Inflammatory Bowel Disease Program. Welcome to the team. We’re proud to have you join us. We look forward to growing and learning alongside you for the years to come. Mohammad Alomari, MD UAMS Health Mauricio Garcia Saenz MD

UAMS enthusiastically welcomes Dr. Mohammad Alomari, Director of the Inflammatory Bowel Disease Program. Welcome to the team. We’re proud to have you join us. We look forward to growing and learning alongside you for the years to come. <a href="/Alomari_MD/">Mohammad Alomari, MD</a> <a href="/uamshealth/">UAMS Health</a> <a href="/MaugarMD/">Mauricio Garcia Saenz MD</a>
Uma Mahadevan (@umamahadevanibd) 's Twitter Profile Photo

Hot of the press: Upadacitinib safety in pregnancy. 128 maternal pregnacies all exposed in the first trimester primarily. MotherToBaby Mette Julsgaard Millie Long link.springer.com/article/10.100…

UAMS Division of Gastroenterology & Hepatology (@uams_gihep) 's Twitter Profile Photo

We extend our gratitude to Dr. Alomari for delivering such a phenomenal and educational Grand Rounds presentation on “Acute Severe Ulcerative Colitis”. Thank you Dr Mohammad Alomari, MD UAMS Health

We extend our gratitude to Dr. Alomari for delivering such a phenomenal and educational Grand Rounds presentation on “Acute Severe Ulcerative Colitis”. Thank you Dr <a href="/Alomari_MD/">Mohammad Alomari, MD</a> 

<a href="/uamshealth/">UAMS Health</a>
Florian Rieder (@ibd_flomd) 's Twitter Profile Photo

💥News from the #STARConsortium #WeTheFibrosisLab💥 Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease | Radiology pubs.rsna.org/doi/10.1148/ra… - Important for Clinical Trial Endpoints in Stricturing Crohn’s disease Miguel Regueiro Christina Ha MD Meena Bewtra

Asad ur Rahman, MD, FACP (@asadurrahman87) 's Twitter Profile Photo

Congratulations to Hammad Zafar on winning FL Gastro Society jeopardy competition among all Florida GI fellowship programs, and to Tolga Erim, DO on delivering the James Borland memorial lecture! Proud to be a part kf Cleveland Clinic Florida GI team!

UAMS Division of Gastroenterology & Hepatology (@uams_gihep) 's Twitter Profile Photo

Thank you UAMS Health for featuring Dr. Alomari in the UAMS News this month. We are thrilled to have him as part of the team here and appreciate the work he is doing in our IBD community. #UAMS #Gastroenterology #IBD Mohammad Alomari, MD

Thank you <a href="/uamshealth/">UAMS Health</a> for featuring Dr. Alomari in the UAMS News this month. We are thrilled to have him as part of the team here and appreciate the work he is doing in our IBD community. #UAMS #Gastroenterology #IBD <a href="/Alomari_MD/">Mohammad Alomari, MD</a>
IBDJournal & CC360 (@ibdjournals) 's Twitter Profile Photo

🌟Micronutrient deficiencies in IBD are associated with adverse disease outcomes 🌟 ⬇️ Selenium ↔️ Worse UC outcomes ⬇️ Zinc ↔️ Worse CD outcomes academic.oup.com/ibdjournal/art… Emily Brownson Jonathan Macdonald

NEJM (@nejm) 's Twitter Profile Photo

In this phase 2 trial, tulisokibart (a tumor necrosis factor–like cytokine 1A monoclonal antibody) was more effective than placebo in inducing clinical remission in patients with ulcerative colitis. Full ARTEMIS-UC trial results: nej.md/4gCAts6

In this phase 2 trial, tulisokibart (a tumor necrosis factor–like cytokine 1A monoclonal antibody) was more effective than placebo in inducing clinical remission in patients with ulcerative colitis. Full ARTEMIS-UC trial results: nej.md/4gCAts6
Stefan Holubar MD MS (@holubarstefan) 's Twitter Profile Photo

Unraveling Twisted Pouch Syndrome: A Narrative Review of Classification, Diagnosis, Treatment, and Prevention academic.oup.com/ibdjournal/art…

UAMS Division of Gastroenterology & Hepatology (@uams_gihep) 's Twitter Profile Photo

Enjoyed a final and fantastic lecture from Dr. Dehmel on Disorders of Gut-Brain Interaction. We will miss these fun and educational sessions. #UAMS #GI

Enjoyed a final and fantastic lecture from Dr. Dehmel on Disorders of Gut-Brain Interaction. We will miss these fun and educational sessions.

#UAMS #GI
Keith Siau (@drkeithsiau) 's Twitter Profile Photo

Why target IL-23 in IBD and what are the differences between IL-23 treatments? Insightful mechanistic data from Maria T. Abreu in this absolutely packed symposium at #UEGWeek 👏🤩

Why target IL-23 in IBD and what are the differences between IL-23 treatments?

Insightful mechanistic data from <a href="/ibddocmaria/">Maria T. Abreu</a> in this absolutely packed symposium at #UEGWeek 👏🤩
Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

#UEGweek a new kid on the block for #IBD my_UEG #Obefazimod: 🔺MOA: Enhances expression miR-124 (micro-RNA) ->⬇️ cytokine & immune cells Clinical remission week 48 🌟43% in non-responders at wk8 🌟60% in responders at wk8 ✅Safety profile consistent x2 yrs ✅FCP & wk90data👇🏽

#UEGweek a new kid on the block for #IBD <a href="/my_ueg/">my_UEG</a> 
#Obefazimod:

🔺MOA: Enhances expression miR-124 (micro-RNA) -&gt;⬇️ cytokine &amp; immune cells

Clinical remission week 48
🌟43% in non-responders at wk8
🌟60% in responders at wk8

✅Safety profile consistent x2 yrs
✅FCP &amp; wk90data👇🏽